Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: TRAVERE THERAPEUTICS, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2023-03-24 to 2024-03-23
Current total value of award: $236500
Description: PHARMACY CHENODAL 250MG (CHENODIOL)